Calendar

RECRUITINGphase readoutNCT07374848: Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors

Sponsor: Zai Lab (Shanghai) Co., Ltd.. Phase: PHASE1. Conditions: Solid Tumors, Sarcomas

full page →ctgov ↗

RECRUITINGphase readoutNCT07668648: Interscalene Brachial Plexus Block Versus Serratus Posterior Superior Intercostal Plane Block for Arthroscopic Shoulder Surgery

Sponsor: Ferit Yetik. Phase: NA. Conditions: Postoperative Pain, Shoulder Arthroscopy

full page →ctgov ↗

RECRUITINGphase readoutNCT06958848: 16F vs 24F Chest Drain After Minimally Invasive Lobectomy and/or Segmentectomy

Sponsor: University Hospital, Basel, Switzerland. Phase: NA. Conditions: Pneumothorax, Pleural Effusion

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05101148: Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children With Neurofibromatosis Type 1 Related Plexiform Neurofibromas

Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Neurofibromatosis Type 1

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT01575548: Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery

Sponsor: National Cancer Institute (NCI). Phase: PHASE3. Conditions: Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v7

full page →ctgov ↗

RECRUITINGphase readoutNCT07406048: Real-World Effectiveness of a Triple Combination BDP/FF/GB Extrafine in a Single Pressurised Metered Dose Inhaler in Brazilian COPD Patients

Sponsor: Chiesi Farmaceutica Ltda.. Phase: . Conditions: COPD (Chronic Obstructive Pulmonary Disease)

full page →ctgov ↗

RECRUITINGphase readoutNCT06761326: Right Versus Left Distal Axillary Vein Cannulation

Sponsor: Alexandria University. Phase: NA. Conditions: Infraclavicular Vein Cannulation, Venous Cannulation

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04208178: Study of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA Mutation

Sponsor: Novartis Pharmaceuticals. Phase: PHASE3. Conditions: Advanced HER2+Breast Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT07714785: Impact of EEG-guided Sevofluorane on Opioid Consumption and Quality of Awakening

Sponsor: Pontificia Universidad Catolica de Chile. Phase: NA. Conditions: Pediatric Anesthesia, Emergence Delirium, Anesthesia, Postoperative Pain, Tonsillectomy

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07645885: Fermented Foods and Bone Health: Investigating the Gut-Bone Axis in Premenopausal Vegan Women

Sponsor: Isabelle Herter-Aeberli. Phase: NA. Conditions: Bone, Bone Health

full page →ctgov ↗

RECRUITINGphase readoutNCT07482943: The Effect of Dapagliflozin on Exercise and Cardiac Functional Status of Patients After Fontan Procedure

Sponsor: The University of Hong Kong. Phase: PHASE4. Conditions: Fontan, Heart Failure, Dapagliflozin, Cardiovascular Diseases, Sodium-GLucose coTransporter-2 Inhibitors

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06604715: A Study of JNJ-87562761 in Participants With Relapsed or Refractory Multiple Myeloma

Sponsor: Janssen Research & Development, LLC. Phase: PHASE1. Conditions: Relapsed or Refractory Multiple Myeloma

full page →ctgov ↗

COMPLETEDphase readoutNCT04670835: Modeling the Impact of Inbound Call Distribution Virtualization in Emergency Medical Communication Centers (EMCCs) on Their Service Level

Sponsor: Nantes University Hospital. Phase: . Conditions: Emergency Medical Service Communication Systems, Health Care

full page →ctgov ↗

COMPLETEDphase readoutNCT07083908: A Comparison of THD® Anopress With High Resolution Anorectal Manometry

Sponsor: King's College Hospital NHS Trust. Phase: NA. Conditions: Obstetric Anal Sphincter Injury

full page →ctgov ↗

Date TBD